“Lynparza is now the only approved targeted medicine in biomarker-selected patients with advanced pancreatic cancer," said AstraZeneca's Dave Fredrickson. AstraZeneca Plc (LON:AZN) announced that the ...

Read More »

Will these 3 FTSE 100 shares make 20% gains in 2020? Barclays, Taylor Wimpey and AstraZeneca

The performances of FTSE 100 shares Barclays PLC (LON:BARC) (BARC.L), Taylor Wimpey plc (LON:TW) (TW.L) and AstraZeneca plc (LON:AZN) (AZN.L) in 2019 has been strong. All three stocks have made gains ...

Read More »

AstraZeneca and Daiichi Sankyo's breast cancer treatment gets US approval

AstraZeneca and Daiichi Sankyo are exploring the further potential of Enhertu in HER2-breast cancer with three ongoing Phase III trials The US Food and Drug Administration (FDA) has approved Enhertu, ...

Read More »

AstraZeneca (LON:AZN) Earns “Overweight” Rating from Barclays

AstraZeneca (LON:AZN)‘s stock had its “overweight” rating reissued by stock analysts at Barclays in a report released on Friday, ThisIsMoney.Co.Uk reports. Several other equities analysts have also ...

Read More »

AstraZeneca (LON:AZN) Given Buy Rating at Shore Capital

Shore Capital reiterated their buy rating on shares of AstraZeneca (LON:AZN) in a research note released on Wednesday morning, ThisIsMoney.Co.Uk reports. Several other brokerages have also issued ...

Read More »